Responses
Late breaking abstracts
5PSQ-080 Identification of pharmacological interactions between ivacaftor/tezacaftor/elexacaftor and dietary supplements/herbs in patients with cystic fibrosis in an outpatient pharmaceutical care unit
Compose a Response to This Article
Other responses
No responses have been published for this article.